Transaction DateRecipientSharesTypePriceValue
31st December 2020Tim B Johnson109Payment by withholding$4.79$522.11
31st December 2020John L Lubniewski62Payment by withholding$4.79$296.98
31st December 2020Byron Lawson24Payment by withholding$4.79$114.96
31st December 2020Shaun D Mc Means31Payment by withholding$4.79$148.49
21st December 2020Ann Hanham3,200Open or private purchase$6.25$20,000.00
14th December 2020Michelle Renee Griffin982Open or private sale$57.42$56,386.44
14th December 2020Michelle Renee Griffin1,651Open or private sale$59.44$98,135.44
14th December 2020Michelle Renee Griffin3,367Open or private sale$58.96$198,518.32
14th December 2020Michelle Renee Griffin6,000Exercise of derivative$7.80$46,800.00
10th December 2020Tim B Johnson34Grant/award etc.$4.87$165.60
Htg Molecular Diagnostics
Htg Molecular Diagnostics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

HTG Molecular Diagnostics, Inc. provides molecular technology solutions that facilitates molecular profiling. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Ticker: HTGM
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 1169987
Employees: 107
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags